Integral Molecular News

Epitope Mapping – Novartis Case Study

How does a biparatopic CXCR2 nanobody inhibit with high potency and efficacy?

Read More

Upcoming Events

 
Antibody Engineering & Therapeutics
12/4 – 12/8 | San Diego, California